Published February 2018 | Version v1
Journal article

Active pharmaceutical ingredients entering the aquatic environment from wastewater treatment works: A cause for concern?

  • 1. Biogeochemistry Research Centre, Plymouth University, Drake Circus, Plymouth PL4 8AA (United Kingdom)
  • 2. Atkins Limited, 500, Park Avenue, Aztec West, Almondsbury, Bristol BS32 4RZ (United Kingdom)
  • 3. AstraZeneca, 1 Francis Crick Ave, Cambridge CB2 0RE (United Kingdom)
  • 4. UK Water Industry Research, Room EA1, 1-7 Great George Street, Westminster, London SW1P 3AA (United Kingdom)
  • 5. wca Environment Ltd, Brunel House, Volunteer Way, Faringdon, Oxfordshire SN7 7YR (United Kingdom)

Description

Highlights: • New data for 19 active pharmaceuticals and 4 metabolites in 45 UK sewage works • Detailed data analysis provided for removal efficiency for the pharmaceuticals • First time risk is related to measured concentrations for all UK sewage works. • Up to 890 works may be causing exceedances of downstream water estimated PNECs. • Ibuprofen, diclofenac, ethinyloestradiol and 2 antibiotics of greatest concern This work reports on the variation in wastewater treatment works (WwTW) influent concentrations of a wide variety of active pharmaceutical ingredients (APIs), their removal efficiency, effluent concentrations and potential risks to the aquatic environment. The research is based on data generated from two large UK-wide WwTW monitoring programmes. Taking account of removal of parent compound from the aqueous phase during treatment in combination with estimates of dilution available it is possible to prioritise the APIs of greatest risk of exceeding estimates of predicted no effect concentrations (PNEC) in receiving waters for all WwTW in the UK. The majority of substances studied were removed to a high degree, although with significant variation, both within and between WwTW. Poorer removal (between influent and effluent) was observed for ethinyloestradiol, diclofenac, propranolol, the macrolide antibiotics, fluoxetine, tamoxifen and carbamazepine. All except the last two of these substances were present in effluents at concentrations higher than their respective estimated PNEC (based on measurement of effluents from 45 WwTW on 20 occasions). Based on available dilution data as many as 890 WwTW in the UK (approximately 13% of all WwTW) may cause exceedances of estimated riverine PNECs after mixing of their effluents with receiving waters. The overall degree of risk is driven by the toxicity value selected, which in itself is controlled by the availability of reliable and relevant ecotoxicological data and consequently the safety factors applied. The dataset and discussion, provides information to assist in the future management of these types of chemicals.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.scitotenv.2017.09.101

Additional details

Identifiers

DOI
10.1016/j.scitotenv.2017.09.101;
PII
S0048969717324439;

Publishing Information

Journal Title
Science of the Total Environment
Journal Volume
613
Journal Page Range
p. 538-547
ISSN
0048-9697
CODEN
STENDL

Optional Information

Copyright
Copyright (c) 2017 Elsevier B.V. All rights reserved.